ACIDS PHARMACEUTICAL PURPOSES

Brand Owner (click to sort) Address Description
PANTALANDIR SyneuRx International Corp. 20F.-10, No.99 Sec. 1, Xintai 5th Rd., Xizhi Dist. New Taipei City 221 Taiwan acids for pharmaceutical purposes; antibiotics; viral antibiotics; cachets for pharmaceutical purposes; cachou for pharmaceutical purposes; candy, medicated; candy for medical purposes; capsules for medicines; chemical preparations for pharmaceutical purposes; chemical preparations for medical purposes; chemical preparations for veterinary purposes; chemical reagents for medical or veterinary purposes; chemico-pharmaceutical preparations; chewing gum for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic substances adapted for medical use; drugs for medical purposes; flour for pharmaceutical purposes; meal for pharmaceutical purposes; freeze-dried food adapted for medical purposes; lyophilized food adapted for medical purposes; germicides; gum for medical purposes; homogenized food adapted for medical purposes; medicated animal feed; medicated dentifrices; medicinal infusions; medicines for human purposes; medicines for veterinary purposes; preparations of microorganisms for medical or veterinary use; nervines; nutraceutical preparations for therapeutic or medical purposes; nutritional supplements; ointments for pharmaceutical purposes; pastilles for pharmaceutical purposes; lozenges for pharmaceutical purposes; pectin for pharmaceutical purposes; pharmaceutical preparations; pharmaceuticals; poultices; pre-filled syringes for medical purposes; salts for medical purposes; sedatives; tranquillizers; suppositories; syrups for pharmaceutical purposes; tonics; inhalation; drugs for pulmonary administration;
PENTARLANDIR SyneuRx International (Taiwan) Corp. 20F.-10, No.99, Sec. 1 Xintai 5th Rd., Xizhi Dist. New Taipei City 221 Taiwan Acids for pharmaceutical purposes, namely, aromatic acids for the treatment of viral infection; antibiotics; viral antibiotics; cachets for pharmaceutical purposes, namely, cachets filled with aromatic acids for the treatment of viral infection; cachou for pharmaceutical purposes, namely, cachou filled with aromatic acids for the treatment of viral infection; candy, medicated; candy for medical purposes; capsules filled with aromatic acids for the treatment of viral infection; chemical preparations for pharmaceutical purposes for the treatment of viral infection; chemical preparations for medical purposes for the treatment of viral infection; chemical preparations for veterinary purposes for the treatment of viral infection; chemical reagents for medical or veterinary purposes; chemico-pharmaceutical preparations for the treatment of viral infection; chewing gum for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic injection and dietetic infusion adapted for medical use; drugs for medical purposes for the treatment of viral infection; flour for pharmaceutical purposes; meal for pharmaceutical purposes; freeze-dried food adapted for medical purposes; lyophilized food adapted for medical purposes; germicides; gum for medical purposes for the treatment of viral infection; homogenized food adapted for medical purposes; medicated animal feed; medicated dentifrices; medicinal infusions for the treatment of viral infection; medicines for human purposes for treatment of viral infection; medicines for veterinary purposes for treatment of viral infection; preparations being cultures of microorganisms for medical or veterinary use; nervines; nutraceutical preparations for treatment of viral infection; nutritional supplements; ointments for treatment of viral infection; cough pastilles for pharmaceutical purposes; cough lozenges for pharmaceutical purposes; pectin for pharmaceutical purposes for treatment of viral infection; pharmaceutical preparations for treatment of viral infection; pharmaceuticals for treatment of viral infection; poultices; pre-filled syringes filled with aromatic acids for the treatment of viral infection; aromatic acid salts for the treatment of viral infection; sedatives; tranquillizers; suppositories for treatment of viral infection; syrups for pharmaceutical purposes for treatment of viral infection; medicated tonics for the treatment of viral infection; inhalation devices, namely, inhalers filled with aromatic acids for the treatment of viral infection; drugs for pulmonary administration for the treatment of viral infection;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention encompasses novel mammalian cell cycle checkpoint genes/DNA repair genes, cDNA or genomic DNA, isolated nucleic acids corresponding thereto, expression vectors comprising said nucleic acids, host cells transformed with said expression vectors, pharmaceutical compositions and the formulation of such compositions comprising said nucleic acids or proteins expressed therefrom, methods for treating a cell using such nucleic acids, proteins or pharmaceutical compositions, and the use of such nucleic acids or proteins in formulating a pharmaceutical preparation.